Network reconstruction of platelet metabolism identifies metabolic signature for aspirin resistance

Scientific Reports

Volumn 4, Issue , 2015, Pages

  Thomas, Alex ^a,d   Rahmanian, Sorena ^b,d   Bordbar, Aarash ^b,d   Palsson, Bernhard Ø ^b,c,d   Jamshidi, Neema ^c,d,e  

^a Department of Bioinformatics and Systems Biology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FATTY ACID; ICOSANOID; NUCLEOTIDE; PROTEOME; REACTIVE OXYGEN METABOLITE;

BIOCHEMISTRY; DRUG EFFECTS; GLYCOLYSIS; HUMAN; METABOLISM; PHYSIOLOGY; PROCEDURES; PROTEOMICS; THROMBOCYTE;

ASPIRIN; BIOCHEMICAL PROCESSES; BLOOD PLATELETS; EICOSANOIDS; FATTY ACIDS; GLYCOLYSIS; HUMANS; NUCLEOTIDES; PROTEOME; PROTEOMICS; REACTIVE OXYGEN SPECIES;

EID: 84922979961     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03925     Document Type: Article

References (53)

1. Antithrombotic Trialists, C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ (Clinical research ed.) 324, 71-86 (2002).
2. Wiviott, S. D. & American Heart Association. Antiplatelet therapy in ischemic heart disease. (Wiley-Blackwell, 2009).
3. Eikelboom, J. W. et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105, 1650-1655 (2002).
4. Mueller, M. R. et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb. Haemost. 78, 1003-1007 (1997).
5. Reed, J. L. Shrinking the metabolic solution space using experimental datasets. PLoS Comput Biol 8, e1002662 (2012).
6. Oberhardt, M. A., Palsson, B. O. & Papin, J. A. Applications of genome-scale metabolic reconstructions. Mol Syst Biol 5, 320 (2009).
7. Varemo, L., Nookaew, I. & Nielsen, J. Novel insights into obesity and diabetes through genome-scale metabolic modeling. Front Physiol 4, 92 (2013).
8. Frezza, C. et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477, 225-228 (2011).
9. Chang, R. L., Xie, L., Bourne, P. E. & Palsson, B. O. Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput Biol 6, e1000938 (2010).
10. Ahn, S. Y. et al. Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis. J Biol Chem 286, 31522-31531 (2011).
11. Jamshidi, N., Miller, F. J., Mandel, J., Evans, T. & Kuo, M. D. Individualized therapy of HHT driven by network analysis of metabolomic profiles. BMC Syst Biol 5, 200 (2011).
12. Ashby, B. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities. Mol Pharmacol 36, 866-873 (1989).
13. Bluestein, D., Niu, L., Schoephoerster, R. T. & Dewanjee, M. K. Steady flow in an aneurysm model: correlation between fluid dynamics and blood platelet deposition. J Biomech Eng 118, 280-286 (1996).
14. Duarte, N. C. et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A 104, 1777-1782 (2007).
15. Guppy, M., Whisson, M. E., Sabaratnam, R., Withers, P. & Brand, K. Alternative fuels for platelet storage: a metabolic study. Vox sanguinis 59, 146-152 (1990).
16. Cohen, P., Derksen, A. & Van den Bosch, H. Pathways of fatty acid metabolism in human platelets. J Clin Invest 49, 128-139 (1970).
17. Reed, J. L., Famili, I., Thiele, I. & Palsson, B. O. Towards multidimensional genome annotation. Nat Rev Genet 7, 130-141 (2006).
18. Mo, M. L., Jamshidi, N. & Palsson, B. O. A genome-scale, constraint-based approach to systems biology of human metabolism. Mol Biosyst 3, 598-603 (2007).
19. Amberger, J., Bocchini, C. A., Scott, A. F. & Hamosh, A. McKusick's Online Mendelian Inheritance in Man (OMIM). Nucleic Acids Res 37, D793-796 (2009).
20. Knox, C. et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 39, D1035-1041 (2011).
21. Lewis, N. E., Nagarajan, H. & Palsson, B. O. Constraining the metabolic genotype-phenotype relationship using a phylogeny of in silico methods. Nat Rev Microbiol 10, 291-305 (2012).
22. Burgard, A. P., Nikolaev, E. V., Schilling, C. H. & Maranas, C. D. Flux Coupling Analysis of Genome-Scale Metabolic Network Reconstructions. Genome. Res. 14, 301-312 (2004).
23. Larhlimi, A. & Bockmayr, A. A New Approach to Flux Coupling Analysis of Metabolic Networks. Lecture Notes in Computer Science Volume 4216, 205-215 (2006).
24. Jamshidi, N. & Palsson, B. O. Systems biology of SNPs. Mol Syst Biol 2, 38 (2006).
25. Cartledge, S., Candy, D. J. & Hawker, R. J. Citrate metabolism by human platelets. Transfusion medicine (Oxford, England) 7, 211-215 (1997).
26. Edenbrandt, C. M. & Murphy, S. Adenine and guanine nucleotide metabolism during platelet storage at 22 degrees C. Blood 76, 1884-1892 (1990).
27. Guppy, M. et al. Fuel choices by human platelets in human plasma. Eur J Biochem 244, 161-167 (1997).
28. Murphy, S., Munoz, S., Parry-Billings, M. & Newsholme, E. Amino acid metabolism during platelet storage for transfusion. Br. J. Haematol. 81, 585-590 (1992).
29. Mo, M. L., Palsson, B. O. & Herrgard, M. J. Connecting extracellular metabolomic measurements to intracellular flux states in yeast. BMC Syst Biol 3, 37 (2009).
30. Schellenberger, J. & Palsson, B. O. Use of randomized sampling for analysis of metabolic networks. J Biol Chem 284, 5457-5461 (2009).
31. Mateos-Cáceres, P. J. et al. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Thromb. Haemost. 103, 160-170 (2010).
32. Becker, L. B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 61, 461-470 (2004).
33. Jamshidi, N. & Palsson, B. O. Using in silico models to simulate dual perturbation experiments: procedure development and interpretation of outcomes. BMC Syst Biol 3, 44 (2009).
34. Famili, I. & Palsson, B. O. The convex basis of the left null space of the stoichiometric matrix leads to the definition of metabolically meaningful pools. Biophys J 85, 16-26 (2003).
35. Jamshidi, N. & Palsson, B. O. Top-down analysis of temporal hierarchy in biochemical reaction networks. PLoS Comput Biol 4, e1000177 (2008).
36. Sauro, H. M. & Ingalls, B. Conservation analysis in biochemical networks: computational issues for software writers. Biophys Chem 109, 1-15 (2004).
37. Papin, J. A., Reed, J. L. & Palsson, B. O. Hierarchical thinking in network biology: the unbiased modularization of biochemical networks. Trends Biochem Sci 29, 641-647 (2004).
38. David, L., Marashi, S. A., Larhlimi, A., Mieth, B. & Bockmayr, A. FFCA: a feasibility-based method for flux coupling analysis of metabolic networks. BMC Bioinformatics 12, 236 (2011).
39. Anfossi, G. & Trovati, M. Role of catecholamines in platelet function: pathophysiological and clinical significance. Eur J Clin Invest 26, 353-370 (1996).
40. Hottz, E. D. et al. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J. Thromb. Haemost. 11, 951-962 (2013).
41. Jobe, S. M. et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 111, 1257-1265 (2008).
42. Kilkson, H., Holme, S. & Murphy, S. Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood 64, 406-414 (1984).
43. Pascale, S. et al. Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target. Blood 119, 3595-3603 (2012).
44. Townsend, D. M., Tew, K. D. & Tapiero, H. The importance of glutathione in human disease. Biomed Pharmacother 57, 145-155 (2003).
45. Nam, H. et al. Network context and selection in the evolution to enzyme specificity. Science 337, 1101-1104 (2012).
46. Orth, J. D., Thiele, I. &Palsson, B. O. What is flux balance analysis? Nat Biotechnol 28, 245-248 (2010).
47. Jerby, L., Shlomi, T. & Ruppin, E. Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol Syst Biol 6, 401 (2010).
48. Mahadevan, R. & Schilling, C. H. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab Eng 5, 264-276 (2003).
49. Kim, D. H. & Motter, A. E. Slave nodes and the controllability of metabolic networks. New J Phys 11, (2009).
50. Vane, J. R. & Botting, R. M. The mechanism of action of aspirin. Thromb Res 110, 255-258 (2003).
51. Sinha, A. K., Rao, A. K., Willis, J. & Colman, R. W. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa. Proc Natl Acad Sci U S A 80, 6086-6090 (1983).
52. Butkus, A., Skrinska, V. A. & Schumacher, O. P. Thromboxane production and platelet aggregation in diabetic subjects with clinical complications. Thromb Res 19, 211-223 (1980).
53. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498-2504 (2003).